Intelligent Bio Solutions Inc (INBS) is not a strong buy for a beginner investor with a long-term strategy at this time. The stock shows mixed technical signals, lacks significant positive catalysts, and has weak financial performance despite revenue growth. Given the absence of strong trading signals or positive sentiment, it is better to hold off on investing in this stock for now.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 44.362, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.662, with resistance at 2.854 and support at 2.469. Overall, the technical indicators suggest a mixed trend with no clear buy signal.
Revenue increased by 47.62% YoY in Q2 2026, indicating some growth potential.
Net income remains negative at -2.68M, EPS dropped by -43.15% YoY, and gross margin decreased significantly to 19.83%, showing poor profitability. No recent news or significant trading trends from insiders or hedge funds.
In Q2 2026, revenue grew by 47.62% YoY to $896,774. However, net income remains negative at -$2,677,590 (up 19.03% YoY), EPS dropped to -2.82 (down 43.15% YoY), and gross margin fell to 19.83% (down 246.78% YoY). The financials indicate revenue growth but poor profitability and declining margins.
No analyst rating or price target data available.
